Matching geography Reports matching your search in: Join Alert Me now! Receive bi-weekly email alerts on new market research Sign up today!
|
Research & Development: market research reports
The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.
New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.
Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.
Research & Development market research reports and industry analysis
|
|
$750.00
|
|
|
$750.00
|
Anti-Obesity Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in ...
|
read more...
|
$2,000.00
|
Osteoporosis Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers ...
|
read more...
|
$2,000.00
|
Anti-Tumor Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in ...
|
read more...
|
$2,000.00
|
Hypertension Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers ...
|
read more...
|
$2,000.00
|
Blood Disease Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major ...
|
read more...
|
$2,000.00
|
Mental Illness Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major ...
|
read more...
|
$2,000.00
|
Lymphoma Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers ...
|
read more...
|
$2,000.00
|
|
|
$2,995.00
|
|
|
$3,500.00
|
|
|
$1,020.00
|
|
|
$5,621.25
|
Angiogenesis in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... number of ceased drugs over the last years amount to another 142 drugs. Angiogenesis In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs ...
|
read more...
|
$5,621.25
|
|
|
$5,621.25
|
Bladder Cancer Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... treated early, the 5 year survival rate is 94%. There are today 98 companies plus partners developing 111 drugs targeting bladder cancer in development. In addition, there are 3 suspended drugs and the accumulated number ...
|
read more...
|
$3,746.25
|
Brain Cancer Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... deadly diseases in the developed world. While primary brain tumors are relatively rare, the chances of survival for patients with the disease are very low, even with the best treatment options currently available. There are ...
|
read more...
|
$5,621.25
|
Cancer Stem Cells Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...
|
read more...
|
$5,621.25
|
|
|
$3,746.25
|
Colorectal Cancer Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... and Erbitux heralded a new era in the disease management, and the emergence of other molecular targeted agents should further push survival to an unprecedented level in the coming years. There are today 299 companies ...
|
read more...
|
$5,621.25
|
|
|
$5,621.25
|
FSH Signaling Pathway in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... FSH signaling which continues further downstream. Activation of PKA leads to phosphorylation of transcription factors like cAMP response element binding protein(CREB) and brings about chromatin remodeling by phosphorylating histone H3. It also enhances the activity ...
|
read more...
|
$5,621.25
|
Gene Therapy in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 95 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...
|
read more...
|
$5,621.25
|
Head and Neck Cancer Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... accumulated number of ceased drugs over the last years amount to another 42 drugs. Head And Neck Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. ...
|
read more...
|
$5,621.25
|
Hematological Cancers Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... 631 hematological cancer drugs in 1265 developmental projects in cancer. In addition, there are 10 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 196 drugs. Hematological Cancers ...
|
read more...
|
$7,496.25
|
< prev 1 2 3 4 5 6 7 8 9 10 next >
|